Collagen peptides type I/III.

Ascorbate keeps the hydroxylase iron centre active, and hydroxyproline is what lets the type I and III triple helix stay folded at body temperature. It is the most load-bearing companion to any collagen peptide.

Prolyl and lysyl hydroxylase carry a ferrous iron centre, so iron status sets how fast new dermal and bone collagen can be hydroxylated. It is a cofactor most skin formulas leave out.

Copper-dependent lysyl oxidase forms the covalent cross-links in both collagen and elastin fibres of the dermis. New fibres stay slack without this step.

Zinc runs the metalloproteinases that trim procollagen and remodel dermal matrix, and it supports the cell division rate of skin and nail tissue. Structure and turnover both draw on it.

Every third residue of a type I or III chain must be glycine for the helix to pack. It is the largest single amino acid requirement of collagen synthesis.

Proline is hydroxylated in the endoplasmic reticulum to hydroxyproline, the residue that stabilises the assembled helix. Substrate and cofactor have to arrive together.

Lysine residues are hydroxylated and then oxidised by lysyl oxidase into the aldehydes that form collagen cross-links. The cross-linking chemistry begins at lysine.

Hyaluronan binds a large volume of water in the dermis between the collagen and elastin fibres, giving skin its plumpness while collagen gives tensile strength. The two occupy different halves of the same matrix.

Bioavailable silicon supports prolyl hydroxylase activity in dermal fibroblasts and the cross-linking of glycosaminoglycans to the collagen network. It is a standard companion in skin, hair and nail collagen blends.

Biotin is the carboxylase cofactor behind the fatty acid and amino acid handling keratinocytes rely on, so it serves the keratin side of hair and nails. Hair and nails are keratin over a collagen-supported bed, which is why the two are combined.

Astaxanthin sits in cell membranes and quenches the singlet oxygen that drives matrix metalloproteinase expression and collagen breakdown. It works on the loss side while collagen peptides work on the supply side.

Tocopherol stops lipid peroxidation chains in skin cell membranes and is regenerated from its radical form by ascorbate, which is already present as the collagen cofactor. The two antioxidants and the collagen substrate form one set.

Type I collagen is the organic template of bone that hydroxyapatite crystallises onto. Providing the scaffold protein and the mineral phase together is how bone matrix formulas are built.

Menaquinone carboxylates osteocalcin so it can bind calcium onto the collagen matrix of bone. It is the step between the collagen scaffold and the mineral.

Elastin fibres give skin recoil while type I and III collagen give it tensile strength, and both are cross-linked by the same copper enzyme. Formulating them together covers both mechanical properties of the dermis.

Manganese is the metal cofactor for the glycosyltransferases that build and attach glycosaminoglycan chains in connective tissue matrix. Collagen peptides supply the peptide side of that matrix, manganese supports the sugar side. Textbook biochemistry, not a combination trial.

Proline and hydroxyproline dominate the collagen triple helix, and endogenous proline is made from glutamate, which glutamine supplies through glutaminase. Adding glutamine feeds the same nitrogen pool that collagen synthesis draws on. This is a precursor relationship rather than a measured outcome.

Arginine is converted by arginase to ornithine, which enters the proline synthesis route through ornithine aminotransferase. That places arginine upstream of the most abundant residue in type I and III collagen. Mechanistic grounding, with no trial of the pair in hand.

Collagen hydrolysate is heavy in glycine, proline and hydroxyproline and low in leucine and tryptophan, so it is a poor trigger of muscle protein synthesis on its own. Pairing it with leucine or a leucine-rich protein covers the amino acids collagen does not bring. The point is complementarity, not that collagen becomes a complete protein.

Whey is rich in the branched-chain amino acids collagen lacks, while collagen peptides deliver the glycine and proline load that connective tissue draws on. Trials of collagen peptides in trained people are run alongside resistance training rather than as a protein replacement, which is the same practical point. Use collagen as an addition to total protein, not a substitute for it.

Creatine acts on phosphocreatine availability during repeated efforts, whereas collagen peptides are studied for tendon and muscle connective tissue adaptation alongside training. The two levers do not overlap, which is why they appear in the same training stack. No study measured the combination, so the grounding is mechanistic plus the shared training context.

Glucosamine feeds the amino sugar pool used to build glycosaminoglycans, the hydrated component of cartilage and connective tissue matrix. Collagen peptides supply the fibrous protein component of the same matrix. Combining them targets two different structural parts, which is the standard formulation rationale.

Chondroitin sulfate is itself a glycosaminoglycan that binds water into the matrix around collagen fibrils. Paired with collagen peptides the formula covers both the fibre and the gel around it. Mechanistic pairing with a long formulation history.

MSM contributes bioavailable sulfur, and sulfation of glycosaminoglycans depends on an adequate sulfate supply. That puts it adjacent to connective tissue matrix assembly rather than on collagen itself. Early grounding, offered as a mechanism.

A 2026 narrative review in Dermatology and Therapy discusses collagen alongside curcumin and glutathione for skin health in ageing women with declining estrogen. A narrative review is a synthesis of other work, not a trial of the three together. Read it as the authors' rationale for combining them, not as measured evidence of an added effect.

The same 2026 narrative review pairs collagen with glutathione on the reasoning that oxidative load in the dermis affects matrix turnover. Glutathione is the cell's main thiol antioxidant and does nothing to collagen structurally. The pairing is a review-level rationale, with no combination trial behind it.

Type I collagen is the protein scaffold of bone, and vitamin D governs the calcium and phosphate handling that mineralises that scaffold. Trials of vitamin D read out through collagen-derived bone turnover markers such as CTX and P1NP, which is a marker of remodelling rather than an outcome. The pairing is mechanistic and the marker literature only mentions collagen in passing.

Proanthocyanidins bind and cross-link collagen fibrils in laboratory preparations, which is why they are used in dentine and tissue-fixation research. Whether an oral dose reaches dermal or tendon collagen in that way is not established. Early, in vitro grounding only.

Pine bark procyanidins inhibit matrix metalloproteinase activity in laboratory systems, the enzymes that break collagen down. Collagen peptides work from the supply side of the same balance. The two are combined on that logic, and the logic sits on cell-level work.

Every ATP-dependent step in protein synthesis, including the assembly of procollagen chains, requires magnesium-bound ATP. That makes magnesium a general enabler rather than a collagen-specific partner. Listed for completeness, at low confidence for any added effect.

Activated charcoal is a non-selective adsorbent that binds organic molecules in the gut lumen, including peptides and amino acids. Taken in the same dose window it can reduce how much of a co-ingested nutrient is absorbed. Separate the two by several hours if both are being used.

Collagen peptides have already been cleaved enzymatically to short chains, so a protease blend has little left to do on them. Where enzymes help is with the rest of a mixed meal, not with the collagen fraction. Stated so a formula does not claim an absorption benefit that the hydrolysis step already delivered.